lactulose has been researched along with Chronic Hepatitis B in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, QH; Huang, J; Huang, YH; Jiang, CH; Liang, LX; Song, HY; Yang, JR | 1 |
| Ding, HG; He, LX; Jin, R; Ma, HB; Shan, J; Tan, YF; Zhang, B; Zhou, L | 1 |
2 trial(s) available for lactulose and Chronic Hepatitis B
| Article | Year |
|---|---|
[The change of intestinal mucosa barrier in chronic severe hepatitis B patients and clinical intervention].
Topics: Administration, Oral; Adolescent; Adult; Amine Oxidase (Copper-Containing); Antiviral Agents; Child; Endotoxins; Female; Glutamine; Hepatitis B, Chronic; Humans; Intestinal Mucosa; Intestine, Small; Lactulose; Male; Mannitol; Middle Aged; Permeability; Treatment Outcome; Young Adult | 2009 |
Combined human growth hormone and lactulose for prevention and treatment of multiple organ dysfunction in patients with severe chronic hepatitis B.
Topics: Adult; Drug Therapy, Combination; Female; Gastrointestinal Agents; Hepatitis B, Chronic; Human Growth Hormone; Humans; Lactulose; Male; Multiple Organ Failure; Severity of Illness Index; Treatment Outcome | 2005 |